PUMA BIOTECHNOLOGY, INC. : Precios y cotizaciones Acción | PBYI | US74587V1070 | MarketScreener
Puma Biotechnology
Puma Biotechnology: Still Bullish At These Prices (NASDAQ:PBYI) | Seeking Alpha
Ex-Puma exec charged with insider trading, hit with criminal charges | Fierce Biotech
La EMA recomienda no aprobar el fármaco de Puma Biotech
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Puma Wins 5-Year Extension of Patent on Main Breast Cancer Treatment Drug Nerlynx - Los Angeles Business Journal
Puma Biotechnology: A Speculative Investment At A Discount (NASDAQ:PBYI) | Seeking Alpha
El negocio bursátil de PUMA BIOTECHNOLOGY – Observatorio de biopolitica
Resumen: Puma Biotechnology y Pierre Fabre firman acuerdo de licencia exclusiva para desarrollar y comercializar NERLYNX® (neratinib) en Europa | Business Wire
Resumen: Puma Biotechnology y Pierre Fabre modifican el acuerdo de licencia de NERLYNX® para incluir la Gran China | Business Wire
Former Puma Biotech Executive Gets U.S. Prison Term for Insider Trading